Literature DB >> 9171250

The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic.

D G Armstrong1, W F Todd, L A Lavery, L B Harkless, T R Bushman.   

Abstract

The aim of this longitudinal study was to report on the clinical characteristics and treatment course of acute Charcot's arthropathy at a tertiary care diabetic foot clinic. Fifty-five diabetic subjects, with a mean age of 58.6 +/- 8.5 years, were studied. All patients were treated with serial total contact casting until quiescence. Following casting and before transfer to prescription footwear, patients were eased into unprotected weightbearing via a removable cast walker. This cohort was followed for their entire treatment course and for a mean 92.6 +/- 33.7 weeks following return to shoes. Pain was the most frequent presenting complaint in these otherwise insensate patients (76%). The mean duration of casting was 18.5 +/- 10.6 weeks. Patients returned to footwear in a mean 28.3 +/- 14.5 weeks. Nine per cent of the population had bilateral arthropathy. These subjects were casted significantly longer than the unilateral group (p < 0.02). Surgery was performed on 25 % of patients, with approximately two-thirds of these procedures involving plantar exostectomies and one-third fusions of affected joints. Patients receiving surgery remained casted significantly longer than non-surgical patients (p < 0.05). Additionally, men were casted longer than women (p < 0.008). Acute Charcot's arthropathy requires prompt, uncompromising reduction in weightbearing stress. Our data show that the ambulatory total contact cast is very effective for this. Regardless of the specific treatment method instituted, it is imperative that appropriate and aggressive treatment be undertaken immediately following diagnosis to help prevent progression to a profoundly debilitating, limb-threatening deformity.

Entities:  

Mesh:

Year:  1997        PMID: 9171250     DOI: 10.1002/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.0.CO;2-8

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  41 in total

1.  Charcot foot.

Authors:  Nicola Mumoli; Alberto Camaiti
Journal:  CMAJ       Date:  2012-03-19       Impact factor: 8.262

2.  Audit of acute Charcot's disease in the UK: the CDUK study.

Authors:  F L Game; R Catlow; G R Jones; M E Edmonds; E B Jude; G Rayman; W J Jeffcoate
Journal:  Diabetologia       Date:  2011-11-08       Impact factor: 10.122

3.  Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP* trial.

Authors:  David G Armstrong; Benjamin A Lipsky; Adam B Polis; Murray A Abramson
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

Review 4.  Risk assessment of the diabetic foot and wound.

Authors:  Stephanie Wu; David G Armstrong
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

5.  Mortality associated with acute Charcot foot and neuropathic foot ulceration.

Authors:  Juliette van Baal; Richard Hubbard; Fran Game; William Jeffcoate
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

6.  Charcot foot reconstruction with combined internal and external fixation: case report.

Authors:  Claire M Capobianco; Crystal L Ramanujam; Thomas Zgonis
Journal:  J Orthop Surg Res       Date:  2010-02-11       Impact factor: 2.359

Review 7.  Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.

Authors:  Brian M Schmidt; Crystal M Holmes
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

Review 8.  Update on Charcot neuroarthropathy.

Authors:  E B Jude; A J Boulton
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Diabetic foot infections in the elderly: primary amputation versus 'foot-sparing surgery'. A case report.

Authors:  Luis R Leon; Shemuel B Psalms; Jodi Walters
Journal:  Int Wound J       Date:  2007-12       Impact factor: 3.315

10.  [Reconstructive foot surgery in cases of diabetic-neuropathic osteoarthropathy].

Authors:  A Koller; U Hafkemeyer; R Fiedler; H H Wetz
Journal:  Orthopade       Date:  2004-09       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.